Northern Indiana Cancer Research Consortium
- Research works
- 28 ▼ 43% vs 2013–17
- Citations
- 893 32.0 per fractional work
- Top-10% rate
- 25.3% record average 16.5%
- Open access
- 37% world 28%
Not ranked overall: Northern Indiana Cancer Research Consortium is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Which keywords describe research at Northern Indiana Cancer Research Consortium?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Clinical Trials, Targeted Therapy, Biomarkers, Metastasis, Immunotherapy, Quality of Life and Radiotherapy.
- Precision Medicine
- Gene Expression
- Neoadjuvant Therapy
- Clinical Practice Guidelines
- Molecular Subtypes
- Taxanes
- Cytoreductive Surgery
- Survival Analysis
- Prognostic Factors
- ALK Inhibitors
- Metastatic Breast Cancer
- Radiotherapy
- Immunotherapy
- Biomarkers
- Clinical Trials
- Chemotherapy
- Targeted Therapy
- Metastasis
- Quality of Life
- Genomic Profiling
- Treatment Guidelines
- EGFR Mutations
- Breast Cancer
- Chemotherapy-Induced Peripheral Neuropathy
- Ovarian Cancer
- Cancer
- Tumor Markers
- Genomic Profiles
- Small-Cell Lung Cancer
- Genomic Analysis
- Tumor Models
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 31 words, with their numbers
- Chemotherapy6▲ 29×16 topics
- Clinical Trials6▲ 32×5 topics
- Targeted Therapy4▲ 59×3 topics
- Biomarkers3▲ 19×6 topics
- Metastasis3▲ 33×6 topics
- Immunotherapy3▲ 14×8 topics
- Quality of Life2▲ 6.7×6 topics
- Radiotherapy2▲ 22×5 topics
- Genomic Profiling2▲ 81×2 topics
- Metastatic Breast Cancer2▲ 116×2 topics
- Treatment Guidelines2▲ 35×2 topics
- ALK Inhibitors2▲ 128×1 topic
- EGFR Mutations2▲ 128×1 topic
- Prognostic Factors2▲ 16×5 topics
- Breast Cancer2▲ 25×7 topics
- Survival Analysis2▲ 22×5 topics
- Chemotherapy-Induced Peripheral Neuropathy2▲ 112×1 topic
- Cytoreductive Surgery2▲ 89×2 topics
- Ovarian Cancer2▲ 63×2 topics
- Taxanes2▲ 112×1 topic
- Cancer2▲ 3.8×13 topics
- Molecular Subtypes2▲ 63×2 topics
- Tumor Markers2▲ 74×2 topics
- Clinical Practice Guidelines1▲ 9.2×7 topics
- Genomic Profiles1▲ 146×1 topic
- Neoadjuvant Therapy1▲ 23×5 topics
- Small-Cell Lung Cancer1▲ 146×1 topic
- Gene Expression1▲ 7.3×4 topics
- Genomic Analysis1▲ 14×1 topic
- Precision Medicine1▲ 14×3 topics
- Tumor Models1▲ 70×1 topic
Which research topics does Northern Indiana Cancer Research Consortium publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Lymphoma Diagnosis and Treatment, Pulmonary Hypertension Research and Treatments and Circular RNAs in diseases.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 0 works
- 2 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 3 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 0 works
- 4 Circular RNAs in diseases Molecular Biology 0 works
- 5 MicroRNA in disease regulation Cancer Research 0 works
- 6 Cutaneous lymphoproliferative disorders research Dermatology 0 works
- 7 Cancer, Lipids, and Metabolism Cancer Research 0 works
- 8 Cancer Cells and Metastasis Oncology 0 works
- 9 Mast cells and histamine Immunology 0 works
- 10 Pancreatic and Hepatic Oncology Research Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Northern Indiana Cancer Research Consortium's research output changed?
Output in 2018–2022 was 43% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in South Bend
- Memorial Hospital of South Bend
- Indiana University South Bend
- South Bend Museum of Art
- Press Ganey
- South Bend Medical Foundation
- Beacon Health System
- Studebaker National Museum
- Fiji Systems (United States)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.